Stem Cell Advisor

This article explores leading stem cell centers within the U.S. and worldwide.  The global regenerative medicine market size is calculated at USD 20.09 billion in 2024 and is expected to be worth USD 139.70 billion by 2034, expanding at a CAGR of 21.4% from 2024 to 2034, as a result of the rising demand for cell and gene therapies. ( source ) The global stem cell therapy market size (sub-set of regenerative medicine) was exhibited at USD 14.15 billion in 2023 and is projected to hit around USD 49.11 billion by 2033, growing at a CAGR of 13.25% during the forecast period 2024 to 2033. ( Nova1Advisor ) Below, we cover leading stem cell centers. Each one has treated large populations of patients with adult stem cells. At least one (Regenexx) is maintaining a Patient Registry to document long-term patient outcomes. Others, like GIOSTAR, have been working with the U.S. FDA on clinical trials related to the treatment of COVID-1...

When you scrape your knee, break a bone, or cut yourself, the body is able to heal itself. But that’s not the case with certain conditions, like diabetes or heart disease. Regenerative medicine, a fairly new field in which experts are looking for therapies and strategies similar to the mechanisms that help your body heal itself, is changing that. What Is Regenerative Medicine? Regenerative medicine first picked up steam in the 1990s when tissue engineering became popular for  stem cell research  and procedures like skin grafting. The goal of regenerative medicine is to replace or reboot tissues or organs damaged because of disease, injury, age, or other issues instead of treating symptoms with medication and procedures. Regeneration in humans happens at three levels: Molecular. This includes small molecules that are the building blocks of your body, like DNA, fats, and carbohydrates. Cellular. This includes cell structures like neurons or axons that are responsible for cell gr...

The global regenerative medicine market size was valued at USD 55.03 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.7% from 2023 to 2030. Several advancements in biological therapies have shifted the preference toward personalized medicinal strategies over traditional treatment methods. This has created significant opportunities for market players who are involved in biological therapeutics development.  Once reserved for the world's pro athletes and billionaires, the global Stem Cell Therapy market size was exhibited at USD 12.9 billion in 2022 and is projected to hit around USD 46.74 billion by 2032, growing at a CAGR of 13.74% during the forecast period 2023 to 2032. ( R ) The COVID-19 outbreak has considerably impacted various markets, including the regenerative medicine and T-cell therapy manufacturing market. The SARS-CoV-2 coronavirus crisis has significantly affected the delivery of CAR T-cell therapies.  The global T-Cell the...